Department of Nuclear Medicine, Cardiac Imaging, University Hospital and University Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
J Nucl Cardiol. 2023 Apr;30(2):800-810. doi: 10.1007/s12350-022-03040-2. Epub 2022 Aug 1.
Pathologic hypertrophy of the cardiac muscle is a commonly encountered phenotype in clinical practice, associated with a variety of structural and non-structural diseases. Coronary microvascular disease is considered to play an important role in the natural history of this pathological phenotype. Non-invasive imaging modalities, most prominently positron emission tomography and cardiac magnetic resonance, have provided insights into the pathophysiological mechanisms of the interplay between hypertrophy and the coronary microvasculature. This article summarizes the current knowledge on coronary microvascular dysfunction in the most frequently encountered forms of pathologic hypertrophy.
心肌病理性肥大是临床实践中常见的表型,与多种结构性和非结构性疾病相关。冠状动脉微血管疾病被认为在这种病理性表型的自然病程中起着重要作用。非侵入性成像方式,尤其是正电子发射断层扫描和心脏磁共振,为理解肥大和冠状动脉微血管之间相互作用的病理生理机制提供了新的认识。本文总结了目前在最常见的病理性肥大形式中,关于冠状动脉微血管功能障碍的知识。